Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
35143 | 51 | 34.7 | 66% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
3807 | 636 | NEFOPAM//IN VITRO CARCINOGENESIS CELLULAR CHEMOTHER//VITRO CARCINOGENESIS CELLULAR CHEMOTHER Y |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | IN VITRO CARCINOGENESIS CELLULAR CHEMOTHER | Address | 11 | 69% | 18% | 9 |
2 | VITRO CARCINOGENESIS CELLULAR CHEMOTHER Y | Address | 7 | 57% | 16% | 8 |
3 | TARGET BASED DRUG | Author keyword | 4 | 75% | 6% | 3 |
4 | RESISTANCE MODIFYING AGENT | Author keyword | 2 | 50% | 6% | 3 |
5 | ENVIRONM CARCINOGENESIS TOXICOL | Address | 1 | 16% | 10% | 5 |
6 | CANCER DRUG THERAPY | Author keyword | 1 | 50% | 2% | 1 |
7 | EXTRATERRITORIAL CRIME | Author keyword | 1 | 50% | 2% | 1 |
8 | HLTH LAW SCI POLICY | Address | 1 | 50% | 2% | 1 |
9 | MALABARICONE A | Author keyword | 1 | 50% | 2% | 1 |
10 | OXALYL BIS N PHENYL HYDROXAMIC ACID OBPHA | Author keyword | 1 | 50% | 2% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | COPPER CHELATE | 4 | 75% | 6% | 3 |
2 | EHRLICHS ASCITES CARCINOMA | 1 | 50% | 2% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Translational study in cancer research | 2002 | 3 | 2 | 100% |
The role of a Schiff base scaffold, N-(2-hydroxy acetophenone) glycinate-in overcoming multidrug resistance in cancer | 2014 | 3 | 127 | 10% |
What are the reasons for negative phase III trials of molecular-target-based drugs? | 2004 | 8 | 15 | 20% |
Intrinsic and acquired drug resistance in malignant tumors | 2008 | 17 | 8 | 13% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IN VITRO CARCINOGENESIS CELLULAR CHEMOTHER | 11 | 69% | 18% | 9 |
2 | VITRO CARCINOGENESIS CELLULAR CHEMOTHER Y | 7 | 57% | 16% | 8 |
3 | ENVIRONM CARCINOGENESIS TOXICOL | 1 | 16% | 9.8% | 5 |
4 | HLTH LAW SCI POLICY | 1 | 50% | 2.0% | 1 |
5 | HOSP UNIT | 1 | 17% | 5.9% | 3 |
6 | METAB BIOCHEM PATHOL | 0 | 33% | 2.0% | 1 |
7 | JINING PEOPLES HOSP 1 | 0 | 25% | 2.0% | 1 |
8 | INVITRO CARCINOGENESIS CELLULAR CHEMOTHERA | 0 | 100% | 2.0% | 1 |
9 | KEY STATE S | 0 | 100% | 2.0% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000153717 | K M AND V MAX//PERFUSED MOUSE LIVER//N DESMETHYLDIAZEPAM |
2 | 0.0000148443 | THEANINE//L THEANINE//COUPLED FERMENTATION WITH ENERGY TRANSFER |
3 | 0.0000135065 | PHARM TRADIT PHARMACOPOEIA//MORACEAE//CHAENOMELES SPECIOSA |
4 | 0.0000098542 | TETRATHIOMOLYBDATE//ATN 224//ANGIOTROPIN CURNP RIBOKINE |
5 | 0.0000090072 | CLIN BIOMARKERS//MITOCHONDRIAL APOPTOSIS SIGNALING//INTESTINAL OXIDATIVE STRESS |
6 | 0.0000081810 | NEEM LEAF GLYCOPROTEIN//IMMUNOREGULAT IMMUNODIAGNOST//NIMBOLIDE |
7 | 0.0000073692 | P GLYCOPROTEIN//MULTIDRUG RESISTANCE//PSC 833 |
8 | 0.0000069652 | S METHYL METHANETHIOSULFONATE//BIO ANTIMUTAGEN//DIAGNOST TOXICIDADE GENET |
9 | 0.0000068880 | LY573636//TASISULAM//NCI 60 |
10 | 0.0000065359 | ALTERNOL//INTENSIVE CARE EQUIPMENT//SEKT NEUROPSYCHOL |